Levi Garraway, Roche’s chief medical officer and head of global product development, said: “The INAVO120 overall survival ...

The UK-wide Innovative Licensing and Access Pathway (ILAP) was first launched in 2021 to reduce the time to market for innovative medicines by offering drug developers a single platform to collaborate ...

Sanofi’s Sarclisa (isatuximab) has been approved by the Medicines and Healthcare product Regulatory Agency (MHRA) as part of a combination treatment for newly diagnosed multiple myeloma (MM).

If 2024 saw an unparalleled acceleration in the wider public’s awareness of AI, then 2025 will be the year when its practical application becomes mainstream.

Novo Nordisk’s Ozempic (semaglutide) has been approved by the US Food and Drug Administration (FDA) to reduce the risk of ...

Biogen has announced that the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) have started ...

Bayer Consumer Health has launched a digital educational resource to support perimenopausal or menopausal patients in the UK.

In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

AstraZeneca (AZ) and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved by the US Food and Drug ...

Open communication Good, open communication between all is clearly paramount before, during and on return to work. But the preference for how that is done, the frequency and what is communicated ...

Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of ...

Bristol Myers Squibb (BMS) has shared promising results from a late-stage study of its dual immunotherapy combination in ...